PRKAG2 Cardiomyopathy: A Case-Control Study on the Diagnostic Yield Of Histopathology and Ultrastructural Analysis
Kinulpe Honorato-Sampaio1, Carla de Oliveira2, Stanley de Almeida Araújo3
1Faculdade de Medicina, Universidade Federal do Vale do Jequitinhonha e Mucuri, Diamantina, MG - Brasil.
Insights
Histopathological examination of PRKAG2 cardiomyopathy reveals significant cardiomyocyte enlargement and abundant cytosolic glycogen accumulation, distinguishing it from other heart conditions. These findings aid in diagnosing PRKAG2 cardiomyopathy.
Area of Science:
- Cardiovascular Pathology
- Molecular Cardiology
- Genetic Heart Diseases
Background:
- Histopathological data on PRKAG2 cardiomyopathy are currently fragmented.
- Understanding PRKAG2 cardiomyopathy's cardiac pathology is crucial for diagnosis and management.
Purpose of the Study:
- To systematically evaluate cardiac pathological features in a large cohort of PRKAG2 cardiomyopathy patients.
- To compare the diagnostic utility of histopathology with genetic sequencing for PRKAG2 cardiomyopathy.
Main Methods:
- Observational, cross-sectional, case-control study.
- Endomyocardial biopsies analyzed via H&E, PAS, Masson's trichrome staining, and transmission electron microscopy.
- Comparison between 18 PRKAG2 cardiomyopathy patients and 11 heart transplant controls.
Main Results:
- PRKAG2 cardiomyopathy hearts showed cardiomyocyte enlargement, vacuolization, minimal fibrosis, and no inflammation.
- Transmission electron microscopy revealed extensive cytosolic glycogen accumulation, primarily perinuclear.
- Glycogen accumulation was consistently present in PRKAG2 patients and absent in controls.
Conclusions:
- Histological and ultrastructural analysis of endomyocardial biopsies reveals distinct features of PRKAG2 cardiomyopathy.
- These findings aid in the pathological diagnosis of PRKAG2 cardiomyopathy.
- Histopathology offers valuable diagnostic insights complementing genetic testing.
Background:
The histopathological features of PRKAG2 cardiomyopathy have been reported in a fragmentary manner.
Objective:
We aimed to systematically evaluate the cardiac pathological features of PRKAG2 cardiomyopathy in a large patient cohort and assess their diagnostic potential compared to genetic sequencing.
Methods:
We conducted an observational, cross-sectional, case-control study including 18 patients with PRKAG2 cardiomyopathy and 11 heart transplant recipients as controls. All patients underwent percutaneous right ventricular endomyocardial biopsy. Tissue samples were analyzed using H&E staining, Periodic Acid-Schiff staining for glycogen, Masson's trichrome for fibrosis, and ultrastructural assessment by transmission electron microscopy. Statistical significance was set at p < 0.05 for all analyses.
Results:
PRKAG2 cardiomyopathy hearts exhibited significant cardiomyocyte enlargement, normal-appearing mitochondria, extensive vacuolization of most myofibers, minimal interstitial fibrosis (only two patients had mild fibrosis), and no inflammatory cell infiltration. Transmission electron microscopy revealed abundant cytosolic glycogen, primarily in the perinuclear region, with additional deposits in intermyofibrillar and subsarcolemmal areas. This pronounced glycogen accumulation, consistently observed in all PRKAG2 patients, was absent in controls.
Conclusion:
Histological and ultrastructural examination of right ventricular endomyocardial biopsy samples reveals a distinct set of features that strongly suggest PRKAG2 cardiomyopathy.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy


